Clinical Trial

IVUS-guided DES Implantation in Coronary Calcification

Study acronym: ULTIMATE IV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 15, 2024 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Coronary calcified lesion is associated with a poor clinical outcome. Intravascular ultrasound (IVUS) provides anatomic information in detail about reference vessel dimensions and lesion characteristics including severity of diameter stenosis, lesion length, and morphology. Both randomized and observational studies have reported the clinical benefits of IVUS guidance for patients with chronic total occlusion (CTO), long lesions, acute coronary syndrome (ACS) with complex bifurcation lesions. Our previous ULTIMATE trial has demonstrated that IVUS-guided drug-eluting stent (DES) implantation significantly improved clinical outcome in all-comers, particularly for patients who had an IVUS-defined optimal procedure, compared with angiography guidance. However, the benefit of IVUS guidance in coronary severe calcification still remains unknown in the modern DES era.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-23; most recent amendment 2024-11-13.
Trial Details
NCT Number NCT05800002
Lead Sponsor Nanjing First Hospital, Nanjing Medical University
Conditions Coronary Artery Disease
Enrollment 864 participants
Start Date 2023-04-07
Primary Completion 2026-03-30 (estimated)
Study Completion 2033-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-15